Feng Zhang
177Patents
41h-index
126Co-inventors
89Inventor score
Filing activity: Jan 9, 2008 → Oct 17, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8697359B1 | CRISPR-Cas systems and methods for altering expression of gene products | Chemistry; Metallurgy | 1,050 | Active |
| US8993233B2 | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains | Chemistry; Metallurgy | 490 | Active |
| US8795965B2 | CRISPR-Cas component systems, methods and compositions for sequence manipulation | Physics | 470 | Active |
| US8871445B2 | CRISPR-Cas component systems, methods and compositions for sequence manipulation | Physics | 448 | Active |
| US8865406B2 | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation | Emerging Cross-Sectional Technologies | 425 | Active |
| US8906616B2 | Engineering of systems, methods and optimized guide compositions for sequence manipulation | Physics | 422 | Active |
| US8945839B2 | CRISPR-Cas systems and methods for altering expression of gene products | Chemistry; Metallurgy | 416 | Active |
| US8999641B2 | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains | Chemistry; Metallurgy | 407 | Active |
| US8771945B1 | CRISPR-Cas systems and methods for altering expression of gene products | Chemistry; Metallurgy | 404 | Active |
| US8932814B2 | CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes | Chemistry; Metallurgy | 397 | Active |
| US8889418B2 | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation | Emerging Cross-Sectional Technologies | 391 | Active |
| US8889356B2 | CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes | Chemistry; Metallurgy | 373 | Active |
| US8895308B1 | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation | Emerging Cross-Sectional Technologies | 365 | Active |
| US9790490B2 | CRISPR enzymes and systems | Emerging Cross-Sectional Technologies | 303 | Active |
| US8440431B2 | TAL effector-mediated DNA modification | Chemistry; Metallurgy | 189 | Active |
| US8440432B2 | Tal effector-mediated DNA modification | Chemistry; Metallurgy | 164 | Active |
| US8450471B2 | TAL effector-mediated DNA modification | Chemistry; Metallurgy | 162 | Active |
| US9822372B2 | CRISPR-Cas component systems, methods and compositions for sequence manipulation | Physics | 152 | Active |
| US9840713B2 | CRISPR-Cas component systems, methods and compositions for sequence manipulation | Physics | 133 | Active |
| US8398692B2 | System for optical stimulation of target cells | Human Necessities | 101 | Active |
| US8586363B2 | TAL effector-mediated DNA modification | Chemistry; Metallurgy | 91 | Active |
| US8815582B2 | Mammalian cell expressing Volvox carteri light-activated ion channel protein (VChR1) | Chemistry; Metallurgy | 80 | Active |
| US8614092B2 | Nucleotide-specific recognition sequences for designer TAL effectors | Chemistry; Metallurgy | 79 | Active |
| US9834791B2 | CRISPR-related methods and compositions with governing gRNAS | Chemistry; Metallurgy | 78 | Active |
| US8450107B1 | Nucleotide-specific recognition sequences for designer TAL effectors | Chemistry; Metallurgy | 78 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.